Full-service CRO for novel drug and biologic development with regulatory expertise
Veristat operates as a science-first CRO and regulatory consultancy for complex drug and biologic programs, with ~30 years in novel therapy development across rare cancers, CNS, endocrine, and infectious disease. The hiring surge (23 roles in 30 days, 75% senior-level) and active SDTM/ADAM data migration project signal a scaling phase driven by regulatory modernization and global expansion—the company is now hiring across 8 countries including Ireland, Switzerland, and India. Tech stack reflects traditional pharma ops (SAS, Salesforce, Excel) with emerging AI adoption (Claude, Cursor, GitHub Copilot), suggesting internal process automation initiatives alongside clinical execution.
Notable leadership hires: Business Development Director
Veristat provides clinical trial design, execution, regulatory strategy, and data management services to pharma and biotech companies developing novel therapeutics. The company serves mid-to-late stage programs requiring complex global coordination, regulatory submissions, and adaptive trial design. With 501–1,000 employees headquartered in Southborough, Massachusetts, Veristat operates across multiple countries and maintains specialized capabilities in biostatistics, statistical programming, medical writing, and CDISC data standardization. Current operational priorities include harmonizing quality management systems across recent acquisitions, migrating legacy data to SDTM/ADAM standards, and expanding commercial and delivery capacity to support accelerating client demand.
Veristat is a full-service CRO and consultancy specializing in clinical trial execution, regulatory strategy, and data management for novel drugs and biologics. They focus on rare cancers, CNS/neurological, endocrine/metabolic, and infectious disease programs.
Veristat is headquartered in Southborough, Massachusetts and actively hires across the United States, Ireland, United Kingdom, India, Switzerland, France, Germany, and Taiwan.
Other companies in the same industry, closest in size